ArticleBlood advances2021

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

Alessandra Tedeschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.